Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Multi-compatible Automation Controller with Data “Turbo Power”

Published: Tuesday, February 04, 2014
Last Updated: Monday, February 03, 2014
Bookmark and Share
Schleicher’s ProNumeric XCI 600 for fast and efficient field networking.

Schleicher has announced its EtherCAT-enabled machine controller, the ProNumeric XCI 600: IPC-based, it allows for fast and efficient field networking. With Windows 8 embedded and an Intel i3 processor facilitate applications with up to 32 interpolating axes.

The dynamic multi-operating system architecture ensures the continuous protection of current processes as well as long-term investment security.

EtherCAT is a powerful network that is internationally established and used by a multitude of component providers. Schleicher Electronic is one of the leading providers of automation solutions and has developed an EtherCAT interface for its own controllers: The "ProNumericXCI600" Schleicher controller supports the common CoE (CAN over EtherCAT) profile and is therefore compatible with nearly all EtherCAT-enabled drives.

The XCI600 is also an IPC-based controller. It is therefore no longer necessary to have an industrial PC for visualization, logging protocols or statistics. The Core i3 Intel processor has two cores with 1.8 GHz each, a 4 GB DDR3 RAM and a 32 GB Solid State Disk (SSD).

Another advantage of the new Schleicher solution is that the VxWorks real-time operating system for machine controllers and Windows 8 embedded run in parallel to facilitate visualization and communication.

The real-time hypervisor ensures reliable tandem operation. It divides the processor performance and concentrates the real-time processes in one core. Switching times are avoided and the operating systems are reliably separated from each other. It is, for example, possible to restart the Windows system without problems while the system continues to operate.

Even a change to a later version does not affect VxWorks. The real-time system is returned to a safe machine state in the event of errors. VxWorks therefore provides a stable platform for many years of machine life cycles.

The Schleicher controller is provided in "Book-PC" format. The dimensions 100x200x200mm (3.93 x7.87 x 7.87 inches) and vertically orientated connectors make the XCI600 very compact. Neighboring devices can be directly placed next to the controller - even in very flat switch cabinets.

Consistent use of power-saving components ensures very low energy consumption, such that there is no need for active cooling in most applications. Additionally, combined with the Schleicher XSL laser module the system produces unparalleled resolution of 1 µs and precision of 1 micron.

The ProNumeric XCI600, like all other Schleicher controllers, focuses on permanent CNC/PLC synchronization.

The "Intelligent Motion Controller" concept allows Schleicher to combine the strengths of both control technologies and to offer smooth movement sequences, efficient production processes and intuitive operation.

The controller can be easily and quickly parameterized on a computer by using the "Schleicher dialog". The integrated web server facilitates simple visualization and operation.

The XCI600 also offers various interfaces to connect peripheral devices: DVI/VGA interface and USB interface, 4x 1 GB Ethernet connections, seven USB interfaces as well as a serial interface for various applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!